The present invention relates to new formulations containing one or more estrogens and 2-Phenyl-1-[4-2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures below: